Sheffield, UK
Thu 09 10:30
OC5.9
Home Waking Salivary Cortisone to screen for Adrenal Insufficiency in Children
Sheffield, UK
Sheffield, United Kingdom
Thu 09 16:40
D1.2
London, UK
Thu 09 16:22
OC8.3
Dysregulated pathways reveal NOVEL mechanistic insights underlying HMGA2-related growth failure in Silver Russell Syndrome
London, UK
Manchester, United Kingdom
Fri 10 09:40
ES2.3
What is CHI? And the role of the CHI Specialist Practitioners
Manchester, UK
Manchester, United Kingdom
Manchester, United Kingdom
London, United Kingdom
Wed 08 11:00
CME2.1
Arginine Vasopressin Deficiency and Postoperative management of water and electrolytes
London, United Kingdom
Bristol, United Kingdom
Ormskirk, UK
Thu 09 12:22
OC7.3
How do Accident and Emergency staff perceive new diabetes technologies? A study across two centers
Ormskirk, UK
Manchester, United Kingdom
Fri 10 10:00
ES2.4
Establishing the CEW specialist Nursing roles in the North West
Manchester, United Kingdom
Liverpool, United Kingdom
Birmingham, UK
Fri 10 12:05
OC9.3
A National Survey on the care and management of Children and Young people with Type 2 Diabetes
Birmingham, UK
Liverpool, UK
Thu 09 10:20
OC5.8
Liraglutide improves metabolic profile, glycaemic dysregulation, quality-of-life and eating behaviours in adolescents with severe obesity
Liverpool, UK
London, UK
Wed 08 14:30
OC3.1
The first description of an MC4R variant in a patient with Kallmann syndrome and obesity
London, UK
Bristol, UK
Fri 10 12:15
OC10.4
The use of Efmody (Modified-release hydrocortisone, MRHC) in Patients with Congenital Adrenal Hyperplasia (CAH): Initial Experience and Patient Feedback
Bristol, UK
Thu 09 12:28
OC6.4
Screening for coeliac disease in paediatric patients diagnosed with Graves’ Disease.
Oxford, UK
Thu 09 11:10
DS1.1
Preparing for a softer landing at diagnosis – how to manage a child with pre-T1D
Oxford, UK
Exeter, United Kingdom
Wed 08 14:00
CME3.2
Monogenic Diabetes in Children and Adolescents-Approach and management
Exeter, United Kingdom
Cornwall, United Kingdom
Thu 09 09:10
CS1.1
Manchester, United Kingdom
Fri 10 14:30
ES3.1
Cardiff, UK
Fri 10 11:55
OC10.2
A Multidisciplinary Approach to the Growth Hormone Shortage
Cardiff, UK
London, UK
Nottingham, UK
Wed 08 14:50
OC3.3
A complex case of Pituitary Gigantism: Overcoming Challenges in Diagnosis and Treatment
Nottingham, UK
Thu 09 09:40
OC5.4
A survey of current clinical care of children and young people with Klinefelter Syndrome in United Kingdom
Nottingham, UK
Thu 09 12:34
OC7.5
Leicester Paediatric Diabetes Unit's ‘Bridge the Gap’ project: Improving access to diabetes technology for children and young people from ethnic minorities and socio-economically deprived families
Nottingham, UK
Bristol, UK
Wed 08 10:00
OC1.1
45,X/46,XY DSD with gender dysphoria: the conundrum around pubertal induction
Bristol, UK
Newcastle-upon-Tyne, United Kingdom
Thu 09 14:40
HDI1.1
How do I manage steroid induced adrenal suppression
Newcastle-upon-Tyne, United Kingdom
Scotland, United Kingdom
Manchester, United Kingdom
Thu 09 15:10
HDI1.2
How do I manage metabolic bone disease of prematurity
Manchester, United Kingdom
Cincinnati, United States
Thu 09 10:10
CS1.3
Rome, Italy
Thu 09 10:00
OC5.6
Can clinical, biochemical and genetic parameters help distinguish congenital hypogonadotrophic hypogonadism from self-limited delayed puberty?
Rome, Italy
Liverpool, UK
Thu 09 16:34
OC8.5
Feasibility of integrating an exercise specialist supported by mHealth technology to increase exercise and physical activity in an adolescent Complications from Excess Weight Service: MOTIVATE-CEW
Liverpool, UK
Southampton, United Kingdom
Thu 09 16:10
D1.1
Cardiff, Wales
Liverpool, United Kingdom
Thu 09 15:10
HD2.2
Stoke On Trent, UK
Wed 08 16:20
OC4.3
Primary Adrenal Insufficiency with muco-candidiasis- A Rare Cause of Familial Glucocorticoid Deficiency due to Thioredoxin reductase deficiency
Stoke On Trent, UK
Cambridge, UK
Wed 08 13:30
CME3.1
Cardiff, UK
Fri 10 12:05
OC10.3
Evaluating the impact of a nurse education refresher session for families who have a child with adrenal insufficiency
Cardiff, UK
Basildon, UK
Thu 09 12:16
OC7.2
Retrospective audit of the East of England, Children and Young People Diabetes Network, out of hours consortium provision
Basildon, UK
Blackburn, United Kingdom
Fri 10 10:00
DS2.3
Manchester, UK
Thu 09 10:10
OC5.7
Breast milk-induced hypercalcaemia – a retrospective study to describe biochemical and radiological outcomes if no intervention is offered.
Manchester, UK
London, UK
Wed 08 16:00
OC4.1
Cortisone reductase deficiency: a rare cause of hyperandrogenaemia and premature adrenarche.
London, UK
Birmingham, UK
Thu 09 12:10
OC7.1
Integrating physical activity in structured education programmes to lower hyperglycaemia in children and young people with type 1 diabetes without increasing risk of hypoglycaemia
Birmingham, UK
Birmingham, UK
Manchester, United Kingdom
Fri 10 14:30
DS3.1
Hospital care at home and virtual wards for diabetes
Manchester, United Kingdom
Bristol, UK
Wed 08 16:10
OC4.2
A deletion at 20p11.21 region involving FOXA2 causing Congenital Hyperinsulinism and extra pancreatic features
Bristol, UK
Thu 09 12:22
OC6.3
Initial experiences of using the Paediatric Sleep Questionnaire (PSQ) to screen for obstructive sleep apnoea in a tier-3 paediatric weight management clinic
Bristol, UK
Manchester, UK
Thu 09 09:30
OC5.3
Origins of the lower vagina and the role of androgens from 20 years’ experience with genitoplasty for 46XX classical congenital adrenal hyperplasia (CAH)
Manchester, UK
Thu 09 16:10
OC8.1
Is there reversal of virilisation after commencing medical replacement therapy for 46XX classical congenital adrenal hyperplasia (CAH)?
Manchester, UK
Manchester, UK
Taunton, UK
Fri 10 12:15
OC9.4
Evaluating the impact of a Health Care Assistant for care of children and young people with type 1 diabetes - “Improving the Time to Care”
Taunton, UK
London, UK
Thu 09 09:20
OC5.2
Gonadotropin treatment for the induction or completion of puberty for males with hypogonadotropic hypogonadism; Two Centre Experience
London, UK
Fri 10 12:45
I-HH – development of a electronic registry for hypogonadotropic hypogonadism, the 4th module in the I-DSD registry
London, UK
Cambridge, UK
London, UK
Manchester, United Kingdom
Fri 10 09:00
ES2.1
Integration of nurse-led virtual reviews with growth hormone device-linked patient adherence information: a mixed method study.
Manchester, United Kingdom
Nottingham, UK
Fri 10 12:25
OC9.5
Impact of using hybrid closed loop system in a tertiary children’s hospital: a single centre experience
Nottingham, UK
Edinburgh, UK
Sheffield, UK
Birmingham, UK
Thu 09 12:10
OC7.1
Integrating physical activity in structured education programmes to lower hyperglycaemia in children and young people with type 1 diabetes without increasing risk of hypoglycaemia
Birmingham, UK
Birmingham, UK
Birmingham, UK
Fri 10 12:45
OC9.7
Personalised carbohydrate prescriptions using individualised calculations prevent over prescribing carbohydrate to newly diagnosed children and young people with type 1 diabetes.
Birmingham, UK
Southampton, UK
Thu 09 16:28
OC8.4
Association of newborn screening of congenital adrenal hyperplasia with outcomes in the first 90 days of life: a multi-centre I-CAH registry analysis of contemporary practice
Southampton, UK
Newry, UK
Derby, UK
Wed 08 10:10
OC1.2
Swabbing for Staphylococcus in skin reactions to diabetic devices: not a rash decision
Derby, UK
Warsaw, Poland
Wed 08 12:10
OC2.2
Hypopituitarism – a rare manifestation in Joubert syndrome: About 4 cases
Warsaw, Poland
Manchester, UK
Fri 10 12:25
OC10.5
PARENTAL PERSPECTIVE ON GENITOPLASTY FOR GIRLS WITH VIRILISING CONGENITAL ADRENAL HYPERPLASIA
Manchester, UK
Glasgow, UK
Fri 10 12:35
OC10.6
An Appraisal on The Quality and Readability of Growth Hormone Therapy Patient Information Developed by Paediatric Endocrine Societies
Glasgow, UK
Belfast, Northern Ireland
Thu 09 12:10
OC6.1
An audit on improving the endocrine management of patients with Duchenne Muscular Dystrophy
Belfast, Northern Ireland
Newry, UK
Birmingham, United Kingdom
Southampton, UK
Wed 08 10:20
OC1.3
Hyperpigmentation related to diabetes technology adhesives: an unusual presentation of Addison’s disease in a child with type 1 diabetes mellitus
Southampton, UK
Exeter, United Kingdom
Thu 09 14:40
HDI2.1
Leeds, United Kingdom
Wed 08 11:30
CME2.2
Osteoporosis in Children and Adolescents-Approach and management
Leeds, United Kingdom
Manchester, United Kingdom
Fri 10 09:40
ES2.3
What is CHI? And the role of the CHI Specialist Practitioners
Manchester, UK
Manchester, United Kingdom
Manchester, United Kingdom
Manchester, UK
Thu 09 12:16
OC6.2
Children with hypophosphatasia treated with asfotase alfa: analysis from the UK Patients Cohort
Manchester, UK
Liverpool, UK
Thu 09 12:34
OC6.5
Growth hormone excess in children with pituitary adenomas associated with endocrine syndromes
Liverpool, UK
Liverpool, United Kingdom
Fri 10 10:00
ES2.4
Establishing the CEW specialist Nursing roles in the North West
Manchester, United Kingdom
Liverpool, United Kingdom
Manchester, UK
Thu 09 09:50
OC5.5
Pre-hypertension Genes in the Avon Longitudinal Study of Parents and Children (ALSPAC) Predict Higher Systolic Blood Pressure in Children from The Manchester BabyGRO Study
Manchester, UK
Cardiff, UK
Fri 10 11:45
OC9.1
Experience of the digital version of SEREN (Structured Education Reassuring Empowering Nurturing), Diabetes at Diagnosis module- improving paediatric diabetes care
Cardiff, UK
London, UK
Wed 08 14:40
OC3.2
A novel maternally inherited GNAS variant in a family with hyperphagia and obesity
London, UK
Fri 10 11:55
OC9.2
Screening for paediatric type 1 diabetes – A qualitative study of parents and stakeholders
Birmingham, UK
Liverpool, UK
Wed 08 12:20
OC2.3
Conquering the Storm: Surgical Intervention Rescues an Adolescent girl with Severe Thyrotoxicosis Refractory to Medical Management
Liverpool, UK
Fri 10 11:45
OC10.1
The real-world experience of Long acting Growth Hormone in Children with Growth Hormone Deficiency
Liverpool, UK
Manchester, United Kingdom
Fri 10 09:15
ES2.2
Metabolic Bone Service at RMCH – optimising patient care
Manchester, United Kingdom
Thu 09 16:16
OC8.2
Rare variants in the MECP2 gene in girls with central precocious puberty
Nottingham, UK
Fri 10 12:55
OC9.8
Manchester, United Kingdom
Fri 10 15:00
DS3.2
Birmingham, UK
Fri 10 11:55
OC9.2
Screening for paediatric type 1 diabetes – A qualitative study of parents and stakeholders
Birmingham, UK
Liverpool, United Kingdom
Fri 10 09:30
DS2.2
Pharmacological management of T2DM - adult perspective
Liverpool, United Kingdom
Wigan, UK
Fri 10 12:35
OC9.6
How does HbA1c compare with OGTT in identifying patients with Diabetes Mellitus and Pre-Diabetes
Wigan, UK
London, United Kingdom
Wed 08 15:30
CME4.1
Interpretation of Urinary steroid profiles in Paediatric Endocrinology
London, United Kingdom
Manchester, United Kingdom
Fri 10 09:00
DS2.1
Clinical Research and Real World Updates of Closed loop systems
Manchester, United Kingdom
Manchester, United Kingdom
Fri 10 15:30
DS3.3
Foot problems in diabetes mellitus: prevention and management
Manchester, United Kingdom
London, UK
Wed 08 12:00
OC2.1
Lessons learned from a case of fungal candida thyroiditis: a rare but serious condition
London, UK
Thu 09 09:10
OC5.1
Endocrine Outcomes in Bardet-Biedl Syndrome from a Large Single-Centre Paediatric Multidisciplinary Clinic
London, UK
Oxford, United Kingdom
Birmingham , UK
Fri 10 13:05
OC9.9
Quality improvement using PDSA cycles improves performance on NPDA key care processes for Birmingham Children's Hospital
Birmingham , UK
Manchester, UK
Fri 10 09:40
ES2.3
What is CHI? And the role of the CHI Specialist Practitioners
Manchester, UK
Manchester, United Kingdom
Manchester, United Kingdom
Workshop
1
Oral
10
Expert
1
Plenary
4
Catering and Social
10
Nurse
0
Other
10
Symposium
15
No Session Type
0
Wed 08 10:00
OC1.1
45,X/46,XY DSD with gender dysphoria: the conundrum around pubertal induction
Bristol, UK
Wed 08 10:10
OC1.2
Swabbing for Staphylococcus in skin reactions to diabetic devices: not a rash decision
Derby, UK
Wed 08 10:20
OC1.3
Hyperpigmentation related to diabetes technology adhesives: an unusual presentation of Addison’s disease in a child with type 1 diabetes mellitus
Southampton, UK
Wed 08 12:00
OC2.1
Lessons learned from a case of fungal candida thyroiditis: a rare but serious condition
London, UK
Wed 08 12:10
OC2.2
Hypopituitarism – a rare manifestation in Joubert syndrome: About 4 cases
Warsaw, Poland
Wed 08 12:20
OC2.3
Conquering the Storm: Surgical Intervention Rescues an Adolescent girl with Severe Thyrotoxicosis Refractory to Medical Management
Liverpool, UK
Wed 08 14:30
OC3.1
The first description of an MC4R variant in a patient with Kallmann syndrome and obesity
London, UK
Wed 08 14:40
OC3.2
A novel maternally inherited GNAS variant in a family with hyperphagia and obesity
London, UK
Wed 08 14:50
OC3.3
A complex case of Pituitary Gigantism: Overcoming Challenges in Diagnosis and Treatment
Nottingham, UK
Wed 08 16:00
OC4.1
Cortisone reductase deficiency: a rare cause of hyperandrogenaemia and premature adrenarche.
London, UK
Wed 08 16:10
OC4.2
A deletion at 20p11.21 region involving FOXA2 causing Congenital Hyperinsulinism and extra pancreatic features
Bristol, UK
Wed 08 16:20
OC4.3
Primary Adrenal Insufficiency with muco-candidiasis- A Rare Cause of Familial Glucocorticoid Deficiency due to Thioredoxin reductase deficiency
Stoke On Trent, UK
Thu 09 09:10
OC5.1
Endocrine Outcomes in Bardet-Biedl Syndrome from a Large Single-Centre Paediatric Multidisciplinary Clinic
London, UK
Thu 09 09:20
OC5.2
Gonadotropin treatment for the induction or completion of puberty for males with hypogonadotropic hypogonadism; Two Centre Experience
London, UK
Thu 09 09:30
OC5.3
Origins of the lower vagina and the role of androgens from 20 years’ experience with genitoplasty for 46XX classical congenital adrenal hyperplasia (CAH)
Manchester, UK
Thu 09 09:40
OC5.4
A survey of current clinical care of children and young people with Klinefelter Syndrome in United Kingdom
Nottingham, UK
Thu 09 09:50
OC5.5
Pre-hypertension Genes in the Avon Longitudinal Study of Parents and Children (ALSPAC) Predict Higher Systolic Blood Pressure in Children from The Manchester BabyGRO Study
Manchester, UK
Thu 09 10:00
OC5.6
Can clinical, biochemical and genetic parameters help distinguish congenital hypogonadotrophic hypogonadism from self-limited delayed puberty?
Rome, Italy
Thu 09 10:10
OC5.7
Breast milk-induced hypercalcaemia – a retrospective study to describe biochemical and radiological outcomes if no intervention is offered.
Manchester, UK
Thu 09 10:20
OC5.8
Liraglutide improves metabolic profile, glycaemic dysregulation, quality-of-life and eating behaviours in adolescents with severe obesity
Liverpool, UK
Thu 09 10:30
OC5.9
Home Waking Salivary Cortisone to screen for Adrenal Insufficiency in Children
Sheffield, UK
Thu 09 12:10
OC6.1
An audit on improving the endocrine management of patients with Duchenne Muscular Dystrophy
Belfast, Northern Ireland
Thu 09 12:16
OC6.2
Children with hypophosphatasia treated with asfotase alfa: analysis from the UK Patients Cohort
Manchester, UK
Thu 09 12:22
OC6.3
Initial experiences of using the Paediatric Sleep Questionnaire (PSQ) to screen for obstructive sleep apnoea in a tier-3 paediatric weight management clinic
Bristol, UK
Thu 09 12:28
OC6.4
Screening for coeliac disease in paediatric patients diagnosed with Graves’ Disease.
Thu 09 12:34
OC6.5
Growth hormone excess in children with pituitary adenomas associated with endocrine syndromes
Liverpool, UK
Thu 09 12:10
OC7.1
Integrating physical activity in structured education programmes to lower hyperglycaemia in children and young people with type 1 diabetes without increasing risk of hypoglycaemia
Birmingham, UK
Birmingham, UK
Thu 09 12:16
OC7.2
Retrospective audit of the East of England, Children and Young People Diabetes Network, out of hours consortium provision
Basildon, UK
Thu 09 12:22
OC7.3
How do Accident and Emergency staff perceive new diabetes technologies? A study across two centers
Ormskirk, UK
Thu 09 12:34
OC7.5
Leicester Paediatric Diabetes Unit's ‘Bridge the Gap’ project: Improving access to diabetes technology for children and young people from ethnic minorities and socio-economically deprived families
Nottingham, UK
Thu 09 16:10
OC8.1
Is there reversal of virilisation after commencing medical replacement therapy for 46XX classical congenital adrenal hyperplasia (CAH)?
Manchester, UK
Thu 09 16:16
OC8.2
Rare variants in the MECP2 gene in girls with central precocious puberty
Thu 09 16:22
OC8.3
Dysregulated pathways reveal NOVEL mechanistic insights underlying HMGA2-related growth failure in Silver Russell Syndrome
London, UK
Thu 09 16:28
OC8.4
Association of newborn screening of congenital adrenal hyperplasia with outcomes in the first 90 days of life: a multi-centre I-CAH registry analysis of contemporary practice
Southampton, UK
Thu 09 16:34
OC8.5
Feasibility of integrating an exercise specialist supported by mHealth technology to increase exercise and physical activity in an adolescent Complications from Excess Weight Service: MOTIVATE-CEW
Liverpool, UK
Fri 10 11:45
OC9.1
Experience of the digital version of SEREN (Structured Education Reassuring Empowering Nurturing), Diabetes at Diagnosis module- improving paediatric diabetes care
Cardiff, UK
Fri 10 11:55
OC9.2
Screening for paediatric type 1 diabetes – A qualitative study of parents and stakeholders
Birmingham, UK
Fri 10 12:05
OC9.3
A National Survey on the care and management of Children and Young people with Type 2 Diabetes
Birmingham, UK
Fri 10 12:15
OC9.4
Evaluating the impact of a Health Care Assistant for care of children and young people with type 1 diabetes - “Improving the Time to Care”
Taunton, UK
Fri 10 12:25
OC9.5
Impact of using hybrid closed loop system in a tertiary children’s hospital: a single centre experience
Nottingham, UK
Fri 10 12:35
OC9.6
How does HbA1c compare with OGTT in identifying patients with Diabetes Mellitus and Pre-Diabetes
Wigan, UK
Fri 10 12:45
OC9.7
Personalised carbohydrate prescriptions using individualised calculations prevent over prescribing carbohydrate to newly diagnosed children and young people with type 1 diabetes.
Birmingham, UK
Fri 10 12:55
OC9.8
Fri 10 13:05
OC9.9
Quality improvement using PDSA cycles improves performance on NPDA key care processes for Birmingham Children's Hospital
Birmingham , UK
Fri 10 11:45
OC10.1
The real-world experience of Long acting Growth Hormone in Children with Growth Hormone Deficiency
Liverpool, UK
Fri 10 11:55
OC10.2
A Multidisciplinary Approach to the Growth Hormone Shortage
Cardiff, UK
Fri 10 12:05
OC10.3
Evaluating the impact of a nurse education refresher session for families who have a child with adrenal insufficiency
Cardiff, UK
Fri 10 12:15
OC10.4
The use of Efmody (Modified-release hydrocortisone, MRHC) in Patients with Congenital Adrenal Hyperplasia (CAH): Initial Experience and Patient Feedback
Bristol, UK
Fri 10 12:25
OC10.5
PARENTAL PERSPECTIVE ON GENITOPLASTY FOR GIRLS WITH VIRILISING CONGENITAL ADRENAL HYPERPLASIA
Manchester, UK
Fri 10 12:35
OC10.6
An Appraisal on The Quality and Readability of Growth Hormone Therapy Patient Information Developed by Paediatric Endocrine Societies
Glasgow, UK
Fri 10 12:45
I-HH – development of a electronic registry for hypogonadotropic hypogonadism, the 4th module in the I-DSD registry
London, UK
Wed 08 11:00
CME2.1
Arginine Vasopressin Deficiency and Postoperative management of water and electrolytes
London, United Kingdom
Wed 08 11:30
CME2.2
Osteoporosis in Children and Adolescents-Approach and management
Leeds, United Kingdom
Wed 08 13:30
CME3.1
Wed 08 14:00
CME3.2
Monogenic Diabetes in Children and Adolescents-Approach and management
Exeter, United Kingdom
Wed 08 15:30
CME4.1
Interpretation of Urinary steroid profiles in Paediatric Endocrinology
London, United Kingdom
Thu 09 09:10
CS1.1
Thu 09 10:10
CS1.3
Thu 09 11:10
DS1.1
Preparing for a softer landing at diagnosis – how to manage a child with pre-T1D
Oxford, UK
Thu 09 14:40
HDI1.1
How do I manage steroid induced adrenal suppression
Newcastle-upon-Tyne, United Kingdom
Thu 09 15:10
HDI1.2
How do I manage metabolic bone disease of prematurity
Manchester, United Kingdom
Thu 09 14:40
HDI2.1
Thu 09 15:10
HD2.2
Fri 10 09:00
DS2.1
Clinical Research and Real World Updates of Closed loop systems
Manchester, United Kingdom
Fri 10 09:30
DS2.2
Pharmacological management of T2DM - adult perspective
Liverpool, United Kingdom
Fri 10 10:00
DS2.3
Fri 10 09:00
ES2.1
Integration of nurse-led virtual reviews with growth hormone device-linked patient adherence information: a mixed method study.
Manchester, United Kingdom
Fri 10 09:15
ES2.2
Metabolic Bone Service at RMCH – optimising patient care
Manchester, United Kingdom
Fri 10 09:40
ES2.3
What is CHI? And the role of the CHI Specialist Practitioners
Manchester, UK
Manchester, United Kingdom
Manchester, United Kingdom
Fri 10 10:00
ES2.4
Establishing the CEW specialist Nursing roles in the North West
Manchester, United Kingdom
Liverpool, United Kingdom
Fri 10 14:30
DS3.1
Hospital care at home and virtual wards for diabetes
Manchester, United Kingdom
Fri 10 15:00
DS3.2
Fri 10 15:30
DS3.3
Foot problems in diabetes mellitus: prevention and management
Manchester, United Kingdom
Fri 10 14:30
ES3.1
0 result(s) found.